In this review, we discuss all sulfur-containing FDA-approved drugs and their structures. The second section of the review is dedicated to structural analysis and is divided into 14 subsections, each focusing on one type of sulfur-containing moiety. A concise graphical representation of each class features drugs that are organized on the basis of structural similarity, evolutionary relevance, and medical indication. This review offers a unique and comprehensive overview of the structural features of all sulfur-containing FDA-approved drugs to date.

中文翻译：

---

美国FDA批准的含有硫原子的药物的分析

在这篇综述中，我们讨论了所有含硫的FDA批准的药物及其结构。综述的第二部分专门进行结构分析，分为14个小节，每个小节重点介绍一种类型的含硫部分。每个类别的简明图形表示均以根据结构相似性，进化相关性和医学适应症进行组织的药物为特征。这篇综述提供了迄今为止所有含硫FDA批准药物的结构特征的独特而全面的概述。